Singapore is a prime location for clinical trials due to its robust regulatory framework, well-equipped medical centers, diverse patient population, and government support for biomedical research. Effective clinical trial management requires careful coordination throughout the process, from feasibility to close-out. CurexBio provides clinical research services in Singapore, offering essential expertise at each stage of the trial lifecycle.
Why is Singapore a crucial spot for the clinical trials?
Figure 1: Singapore and its capabilities for clinical trial implementation—CurexBio
- Regulatory Clarity: Clinical trials for health products are regulated by the Health Sciences Authority (HSA) and must comply with national laws like the Human Biomedical Research Act relating to research involving human subjects.
- International standards: Uphold that trials adhere to ICH-GCP principles, ensuring that data generated in Singapore is respected in global submissions.
- Research infrastructure: Comprises public healthcare clusters, academic institutions, and dedicated research units, which collectively provide seasoned investigators and robust site capabilities.
- Strategic hub: Singapore serves as a strategic hub for multi-country studies in the Asia-Pacific region due to its advantageous location.
Stage 1: Feasibility Evaluation and Planning Stage
Good trials necessitate realistic planning, with sponsors needing to confirm the feasibility of a study in Singapore before submission.
How CurexBio supports this stage
Site and investigator feasibility assessments, evaluation of patient population and recruitment rates, regulatory pathway assessment (including trial authorization versus notification based on product and phase), and planning of budget and timelines are essential components of the trial preparation process.
Stage 2: Study Start-up
Start-up phases often experience delays due to parallel processes involving documents, approvals, and contracts, where any gaps can impede the timeline for first-patient-in.
Important activities include:
Figure 2: Important Activities Supported by CurexBio
How does CurexBio support this stage?
The summary of activities includes preparing and quality-checking submission packages, coordinating with ethics committees and regulators, supporting contract negotiation, and ensuring site readiness for day one through site initiation.
Stage 3: Trial Conduct and Monitoring
Once enrollment opens, the primary focus becomes the protection of participants, ensuring data reliability, and maintaining the study’s schedule.
Core activities:
Clinical monitoring involves both on-site and remote verification of protocol compliance and source data. Safety management focuses on the timely reporting of adverse and serious adverse events to sponsors, ethics committees, and regulators. Data management ensures clean, consistent, and auditable data capture and query resolution. Recruitment and retention strategies aim to maintain enrollment and participant engagement. Protocol amendments are managed to facilitate changes and approvals without disrupting the study.
Figure 3: After enrollment, core responsibilities by the CurexBio team
How CurexBio supports this stage
Risk-based monitoring involves safety reporting support, ongoing site communication, and proactive tracking of enrollment and quality metrics.
Stage 4: Data Analysis and Medical Writing
Trial data’s value hinges on clear interpretation and communication, with high-quality documentation being crucial for regulators, journals, and the scientific community.
Figure 4: Typical Deliverables
How CurexBio supports this stage:
Coordinating biostatistics and medical writing so that results are accurate, consistent, and submission-ready.
Stage 5: Close-Out and Archiving
A trial requires proper close-out to ensure data integrity and maintain inspection readiness, even after the last participant leaves.
Figure 5: Key activities of close-out and archiving—CurexBio
How CurexBio supports this stage:
Our team proposes structured close-out checklists, trial master file reviews, and audit and inspection readiness support.
Common Challenges and How to Avoid Them
| Challenge | How support helps |
| Delayed approvals from incomplete submissions | Pre-submission quality checks |
| Slow recruitment | Realistic feasibility and early site engagement |
| Protocol deviations | Training, clear communication, and risk-based monitoring |
| Inconsistent documentation | Standardised templates and centralised oversight |
| Inspection findings | Continuous inspection-readiness practices |
Why Choose CurexBio for Clinical Research Services in Singapore?
Running a clinical trial in Singapore requires balancing speed, compliance, and quality. Collaborating with a knowledgeable partner in local regulations and site landscapes aids sponsors in achieving this balance.
Figure 6: CurexBio supports clinical research projects.
CurexBio provides comprehensive clinical research services in Singapore, assisting sponsors, biotech firms, and academic researchers from initial feasibility stages to final project closure. With end-to-end clinical research services in Singapore, CurexBio supports sponsors throughout the clinical trial lifecycle.
Get in Touch: Planning a clinical trial in Singapore? Contact CurexBio for comprehensive support throughout your study.
